NCT00268645View on ClinicalTrials.gov

Insulin Glargine in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

534

Participants

Timeline

Start Date

September 30, 2004

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin Glargine

Trial Locations (1)

Unknown

Sanofi-Aventis, Istanbul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00268645 - Insulin Glargine in Type 2 Diabetes | Biotech Hunter | Biotech Hunter